A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease | MicrobiomeTrials← Back to trialsNCT07106021
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-07-17Est. Completion: 2027-09
Enrollment target: 12 participants Locations- University of Arizona, Tucson, Arizona, United States
- Keck Medical Center of University of Southern California, Los Angeles, California, United States
- The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Parkinson DiseaseProgressive Supranuclear Palsy
To perform a prospective cohort study with \[(18)F\]fluoroethoxybenzovesamicol (FEOBV) brain PET at baseline and 2-year …
Ann Arbor, United StatesEst. completion Jun 30, 2027
Idiopathic Parkinson's Disease (PD)
This multicenter retrospective observational study investigates the incidence of malignant neoplasms in Parkinson's dise…
Brindisi, ItalyEst. completion Dec 2026